The Effect of Pentoxifylline on Oxidative Stress in Chronic Kidney Disease Patients With Erythropoiesis-Stimulating Agent Hyporesponsiveness: Sub-Study of the HERO Trial

Redox Report - United Kingdom
doi 10.1179/1351000215y.0000000022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Erythropoiesis-Stimulating Agents Increase the Risk of Acute Stroke in Patients With Chronic Kidney Disease

Kidney International
Nephrology
2011English

Iron Repletion Is Associated With Reduction in Platelet Counts in Non-Dialysis Chronic Kidney Disease Patients Independent of Erythropoiesis-Stimulating Agent Use: A Retrospective Cohort Study

BMC Nephrology
Nephrology
2014English

Effects of Anemia Correction by Erythropoiesis-Stimulating Agents on Cardiovascular Function in Non-Dialysis Patients With Chronic Kidney Disease

International Heart Journal
MedicineCardiovascular MedicineCardiology
2012English

Oxidative Stress in Chronic Kidney Disease

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2018English

Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents

Current Medical Research and Opinion
Medicine
2008English

Oxidative Stress in Chronic Kidney Disease

Renal Replacement Therapy
2018English

Results of a Study Evaluating Patient's Perception Regarding Their Erythropoiesis Stimulating Agent Treatment in Chronic Kidney Disease Using a Choice Based Conjoint Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Dietary Antioxidents and Oxidative Stress in Predialysis Chronic Kidney Disease Patients

Journal of Nephropathology
Nephrology
2012English

The Effect of Diet on the Survival of Patients With Chronic Kidney Disease

Nutrients
NutritionFood ScienceDietetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy